Fighting the Big Three in Uganda

Partnership Objectives

  1. Positively impact the incidence of, treatment of and patient outcomes for Malaria, TB and HIV.
  2. Establish Village Health Teams to provide community level health services for these diseases and a link from the villages to the district health services.
  3. Improve the infrastructure for diagnosis and long-term management of these diseases.

A youth peer group led sensitization and HIV counseling and testing session for students of Kiboga Progressive Secondary School. A youth peer group led sensitization and HIV counseling and testing session for students of Kiboga Progressive Secondary School. Copyright AstraZeneca

What are the health needs and challenges?

There is a high prevalence of TB among young children and co-infected patients. In Uganda, fifty (50%) percent of TB patients are HIV positive and 30 % of AIDS-related deaths there are attributed to TB.

Description of partnership activities and how they address needs and challenges

Since 2007, Amref Health Africa have been working with AstraZeneca on a project to help tackle the "big three" diseases; malaria, HIV/AIDS and TB. Despite evident links between these three major diseases, an integrated approach to manage the problem had not been attempted in Uganda before.

As well as helping to strengthen support services, such as laboratory services, transport systems and drugs, the project also looks to improve successful treatment of TB by training community health workers to support TB patients to take their drugs correctly.

Lessons learned

The Village Health Team model had a greater than expected impact in linking patients to services. Detailed needs assessment with involvement of stakeholders at the start was key to determining best interventions. A broad approach directed the project to fundamental capacity building with strong leverage beyond the initial disease scope.

Summary of impact through December 2013 and forward looking information

Over 1,100 village health teams were trained as well as a number of highly skilled lab technicians. 100,000 people across the two districts were educated about the three diseases, either by peer educators or through outreach days within schools and communities.

Hospital Admissions for and mortality from malaria halved; uptake of HIV testing increased 49%, HIV positivity down from 6.7% to 4.4%. There was a four-fold increase in TB testing with TB mortality down from 2.4% to 0.24%.



Integrating malaria, HIV/AIDS and TB treatment in Luwero and Kiboga

Partnership information

Company(ies) AstraZeneca

Partner(s) African Medical and Research Foundation (AMREF)

Type of Partner(s) NGOs

Therapeutic Focus Infectious Diseases

Disease(s) HIV/AIDS, Malaria, Tuberculosis

Program Type(s) Health System Infrastructure - Training, Prevention Programs - Awareness & Outreach

Targeted Population(s) Children, Health professionals, Patients in needs of treatment, Youth

Region(s) Sub-Saharan Africa

Number of Countries 1

Country(ies) Uganda

Start Date 2007

More information AMREF

Completed date 2012

« I am so delighted that I have had this training, now I can do my given task as an expert from the National Medical Stores with confidence. »

Acio Susan, Officer in charge of Kikonda Health Centre III